Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

Capivasertib addition to standard therapy extended rPFS by 7.5 months in PTEN-deficient metastatic hormone-sensitive prostate ...

Prostate cancer is one of the most common and serious health issues affecting men worldwide. In its early stages, the ...

Prostate cancer is among the most common types of cancer found in men. It develops in the prostate gland, a small organ ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

CINCINNATI (WKRC) — Former President Joe Biden was diagnosed with an aggressive form of prostate cancer that has spread to the bone, but doctors remained optimistic about his prognosis. Dr. Mark ...